Serum fibroblast growth factor 21 is a superior biomarker to other adipokines in predicting incident diabetes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Serum fibroblast growth factor 21 is a superior biomarker to other adipokines in predicting incident diabetes

Published:2016-09-29 Issue:1 Volume:86 Page:37-43
ISSN:0300-0664
Container-title:Clinical Endocrinology
language:en
Short-container-title:Clin Endocrinol

Author:

Woo Yu Cho¹,Lee Chi Ho¹²,Fong Carol H.Y.¹,Xu Aimin¹²³,Tso Annette W.K.¹,Cheung Bernard M.Y.¹²³,Lam Karen S.L.¹²³

Affiliation:

1. Department of Medicine; The University of Hong Kong; Hong Kong China

2. State Key Laboratory of Pharmaceutical Biotechnology; The University of Hong Kong; Hong Kong China

3. Research Centre of Heart; Brain; Hormone and Healthy Aging; The University of Hong Kong; Hong Kong China

Funder

Research Grant Council, Hong Kong

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism,Endocrinology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/cen.13229/fullpdf

Reference31 articles.

1. Fibroblast growth factor 21 as an emerging metabolic regulator: clinical perspectives;Woo;Clinical Endocrinology,2013

2. FGF21 Revolutions: Recent Advances Illuminating FGF21 Biology and Medicinal Properties;Kharitonenkov;Trends in Endocrinology and Metabolism,2015

3. The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes;Gaich;Cell Metabolism,2013

4. A Long-Acting FGF21 Molecule, PF-05231023, Decreases Body Weight and Improves Lipid Profile in Non-human Primates and Type 2 Diabetic Subjects;Talukdar;Cell Metabolism,2016

5. Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans;Zhang;Diabetes,2008

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Connecting the Dots: FGF21 as a Potential Link between Obesity and Cardiovascular Health in Acute Coronary Syndrome Patients;Current Issues in Molecular Biology;2024-08-03

2. Plasma FGF21 Concentration in Kidney Transplant Patients—Results from Prospective and Cross-Sectional Studies;Journal of Clinical Medicine;2024-07-22

3. The role of FGF21 in the interplay between obesity and non-alcoholic fatty liver disease: a narrative review;Romanian Journal of Morphology and Embryology;2024-07-15

4. Potential of FGF21 in type 2 diabetes mellitus treatment based on untargeted metabolomics;Biochemical Pharmacology;2024-07

5. Targeted Proteomics Reveals Functional Targets for Early Diabetes Susceptibility in Young Adults;Circulation: Genomic and Precision Medicine;2024-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3